why choose us

Clinical Trials Search

Showing 7,390 of 132,963 result(s)
An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer

Status: Completed

Condition: Multiple Sclerosis

Interventions: Attention Biases App CT-100-D-004-A Digital Neuro-activation and Modulation (DiNaMo) component uses implicit training to redirect and strengthen atten

Date: 2023-11-01

Neural Correlates During Alcohol Intoxication

Status: Completed

Condition: Alcohol Use Disorder

Interventions: 95% Ethanol diluted in Grape-flavored drink

Date: 2023-11-01

Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy

Status: NOT_YET_RECRUITING

Condition: Ischemic Heart Disease

Interventions: The study product will consist of 100 million UC-MSCs suspended in a final volume of 60 ml given at a rate of 1.6 million cells;min.
The pro

Date: 2023-11-01

Why in Hospital After Wedge Resection

Status: Completed

Condition: Thoracic Surgery, Video-Assisted

Interventions:

Date: 2023-11-01

Dextrose Concentration Decline Rate in Vivo

Status: COMPLETED

Condition: Dextrose Concentration

Interventions:

Step one: 30 mL of 12.5%;0.1% lidocaine will be injected into the knee using an inferomedial approach.
Using ultrasound guidance, a 20-ga

Date: 2023-11-01

Drug Nephrotoxicity Amelioration by N-acetylcysteine

Status: COMPLETED

Condition: Drug-Induced Nephropathy

Interventions: N-acetylcysteine sachets 600 mg twice daily

Date: 2023-11-01

Integrating Brain, Neurocognitive, and Computational Tools in OUD

Status: Completed

Condition: Opioid Use Disorder

Interventions: The Penn Computerized Neurobehavioral Battery (CNB) consists of a series of cognitive tasks, measuring accuracy and speed of performance in major cogn

Date: 2023-11-01

Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)

Status: NOT_YET_RECRUITING

Condition: Hypertension

Interventions: The recommended evidence-based interventions include therapeutic lifestyle change and medical treatment of hypertension

Date: 2023-11-01

Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer

Status: NOT_YET_RECRUITING

Condition: Limited Stage Lung Small Cell Carcinoma

Interventions: Receive Cisplatin

Date: 2023-11-01

A Phase 2 Study to Assess the Efficacy and Safety of KHK4951 in Patients With Diabetic Macular Edema

Status: NOT_YET_RECRUITING

Condition: Diabetic Macular Edema (DME)

Interventions: KHK4951 eye drop for 36 weeks until end of the trial

Date: 2023-10-31